Showing results (81-90 of 98) with videos related to
Sort By:
Pageof 10
Journal of the American Heart Association|September 30, 2024
Selection of Home Treatment and Identification of Low-Risk Patients With Pulmonary Embolism Based on Simplified Pulmonary Embolism Severity Index Score in the Era of Direct Oral AnticoagulantsRyusuke Nishikawa, Yugo Yamashita, Takeshi Morimoto, et al.Journal of the American Heart Association|July 31, 2024
Temporal Changes in Long-Term Outcomes of Venous Thromboembolism From the Warfarin Era to the Direct Oral Anticoagulant EraKazuhisa Kaneda, Yugo Yamashita, Takeshi Morimoto, et al.JACC. Cardiooncology|June 17, 2026
A Bleeding Risk Score for Cancer-Associated Venous Thromboembolism in Patients Receiving Direct Oral AnticoagulantsTomoyuki Nagai, Naohiko Nakanishi, Yugo Yamashita, et al.Journal of Intensive Care|November 4, 2024
Clinical characteristics and short-term outcomes of patients with critical acute pulmonary embolism requiring extracorporeal membrane oxygenation: from the COMMAND VTE Registry-2Kensuke Takabayashi, Yugo Yamashita, Takeshi Morimoto, et al.Circulation Journal : Official Journal of the Japanese Circulation Society|September 28, 2025
Concomitant Antiplatelet Therapy in Patients With Venous Thromboembolism Treated With Anticoagulants - Insights From the COMMAND VTE Registry-2Kazuhisa Kaneda, Yugo Yamashita, Takeshi Morimoto, et al.Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|August 26, 2025
Impact of the Balloon Pulmonary Angioplasty on the Diagnosis of Chronic Thromboembolic Pulmonary Hypertension: From the COMMAND VTE Registry-2Tatsunori Noto, Nobutaka Ikeda, Yugo Yamashita, et al.Thrombosis and Haemostasis|April 29, 2024
Edoxaban, Rivaroxaban, or Apixaban for Cancer-Associated Venous Thromboembolism in the Real World: Insights from the COMMAND VTE Registry-2Daisuke Sueta, Yugo Yamashita, Takeshi Morimoto, et al.Journal of Thrombosis and Thrombolysis|May 28, 2025
Edoxaban treatment without initial heparin lead-in for acute venous thromboembolism: insight from the COMMAND VTE registry-2Yuta Tsujisaka, Yugo Yamashita, Takeshi Morimoto, et al.Circulation Journal : Official Journal of the Japanese Circulation Society|July 2, 2025
Prediction Score for Major Bleeding in Patients With Venous Thromboembolism Receiving Direct Oral Anticoagulants - Insights From the COMMAND VTE Registry-2Satoshi Ikeda, Yugo Yamashita, Takeshi Morimoto, et al.Research and Practice in Thrombosis and Haemostasis|December 5, 2024
Incidence and risk factors of ischemic stroke in patients with cancer-associated venous thromboembolism: from the Contemporary Management and Outcomes in Patients With Venous Thromboembolism Registry-2Toru Sato, Yoshito Ogihara, Yugo Yamashita, et al.Pageof 10